Abstract
The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway.
Keywords: Activated protein C pathway, regulation of coagulation, intracellular signaling effects, endothelial protein C receptor, thrombomodulin, fibrinolysis, sepsis
Current Genomics
Title: Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway
Volume: 6 Issue: 6
Author(s): S. H. Slofstra and H. T. Cate
Affiliation:
Keywords: Activated protein C pathway, regulation of coagulation, intracellular signaling effects, endothelial protein C receptor, thrombomodulin, fibrinolysis, sepsis
Abstract: The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway.
Export Options
About this article
Cite this article as:
Slofstra H. S. and Cate T. H., Perspectives of Activated Protein C in the Vasculature: Update on Proposed Roles of the Protein C Pathway, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774482963
DOI https://dx.doi.org/10.2174/138920205774482963 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Current Drug Targets L-PRP/L-PRF in Esthetic Plastic Surgery, Regenerative Medicine of the Skin and Chronic Wounds
Current Pharmaceutical Biotechnology The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Cardioprotective effects of Aronia melanocarpa anthocynanins. From laboratory experiments to clinical practice.
Current Pharmaceutical Design Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design Host Immune Responses to Aeromonas Virulence Factors
Current Immunology Reviews (Discontinued) Smoking and Hypertension: Effects on Clinical, Biochemical and Pathological Variables Due to Isolated or Combined Action on Cardiovascular System
Current Pharmaceutical Design Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Current Drug Targets Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects
Current Vascular Pharmacology Regulation of Gene Expression in Vascular Cells by Coagulation Proteins
Current Drug Targets Development of New Fibrinolytic Agents
Current Pharmaceutical Design Plasma Level of D-dimer is an Independent Diagnostic Biomarker for Deep Venous Thrombosis in Patients with Ischemic Stroke
Current Neurovascular Research Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Dynamic Role of Microparticles in Type 2 Diabetes Mellitus
Current Diabetes Reviews Keratin-Based Biomaterials for Biomedical Applications
Current Drug Targets Proinflammatory Activities of Leptin in Non-Autoimmune Conditions
Inflammation & Allergy - Drug Targets (Discontinued) Natural Phenolic Compounds as Cardiovascular Therapeutics: Potential Role of their Antiinflammatory Effects
Current Vascular Pharmacology The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Clinical Utility of Biomarkers in Premature Atherosclerosis
Current Medicinal Chemistry Molecularly Imprinted Sol-Gel Materials for Medical Applications
Current Topics in Medicinal Chemistry